WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012107575) NOVEL FORMULATIONS FOR DERMAL, TRANSDERMAL AND MUCOSAL USE 2
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/107575    International Application No.:    PCT/EP2012/052340
Publication Date: 16.08.2012 International Filing Date: 10.02.2012
IPC:
A61K 9/00 (2006.01), A61K 47/06 (2006.01), A61K 47/10 (2006.01), A61K 47/14 (2006.01), A61K 9/70 (2006.01)
Applicants: Moberg Derma AB [SE/SE]; Gustavslundsvägen 42, 5 tr S-167 51 Bromma (SE) (For All Designated States Except US).
LINDAHL, Åke [SE/SE]; (SE) (For US Only).
KAUFMANN, Peter [US/SE]; (SE) (For US Only)
Inventors: LINDAHL, Åke; (SE).
KAUFMANN, Peter; (SE)
Agent: Mc NEENEY, Stephen P.; Potter Clarkson LLP The Belgrave Centre Nottingam, NG1 5GG (GB)
Priority Data:
61/441,346 10.02.2011 US
Title (EN) NOVEL FORMULATIONS FOR DERMAL, TRANSDERMAL AND MUCOSAL USE 2
(FR) NOUVELLES FORMULATIONS POUR UTILISATION DERMIQUE, TRANSDERMIQUE ET MUQUEUSE
Abstract: front page image
(EN)A dermal, transdermal and/or mucosal formulation comprising an active pharmaceutical ingredient, a pharmaceutically acceptable solvent, and an anti-solvent, wherein the active pharmaceutical ingredient is soluble in the solvent in the absence of the anti-solvent, and wherein the active pharmaceutical ingredient is in the solid state in the solvent in the presence of the anti-solvent. A method for increasing the stability of an active pharmaceutical ingredient.
(FR)L'invention concerne une formulation dermique, transdermique et/ou muqueuse comprenant un ingrédient pharmaceutiquement actif, un solvant pharmaceutiquement acceptable et un anti-solvant, dans laquelle l'ingrédient pharmaceutiquement actif est soluble dans le solvant en l'absence de l'anti-solvant, et dans laquelle l'ingrédient pharmaceutiquement actif est à l'état solide dans le solvant en présence de l'antisolvant. L'invention concerne un procédé pour augmenter la stabilité d'un ingrédient pharmaceutique actif.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)